This week marks a major milestone in the evolution of the CoMPaSS-NMD project. On Thursday, April 16th, and Friday, April 17th, our consortium will host two critical workshops to present the ATLAS Platform to our international Scientific Advisory Board (SAB) for its first external expert evaluation. Until now, the ATLAS has undergone rigorous internal [...]
The CoMPaSS-NMD project is reaching a major milestone in its Young Investigator Training (YIT) initiative. On April 21, 2026, we will host our fifth and final webinar: "The CoMPaSS-NMD ATLAS: A New Tool for Clinicians and Researchers." Neuromuscular diseases (NMDs) are often rare and heterogeneous, with similar phenotypes hiding different underlying mechanisms. The CoMPaSS-NMD [...]
On March 3, 2026, the CoMPaSS-NMD project hosted a landmark event at TECNALIA Research & Innovation in Donostia-San Sebastián, also accessible globally via a live stream. The event, "Ethics and Regulation in AI for Health," arrived at a critical juncture as the European healthcare sector navigates the implementation of the EU AI Act and [...]
For many living with rare diseases, the "diagnostic odyssey" is a gruelling reality—a path often marked by years of uncertainty, misdiagnoses, and emotional strain. On 12 February 2026, the CoMPaSS-NMD project will take a significant step towards shortening this journey as we host a major press conference at the Sala Stampa of the Chamber [...]
Revolutionizing Diagnosis for Hereditary Neuromuscular Diseases The CoMPaSS-NMD project is making headlines for its innovative approach to transforming the landscape of rare disease diagnosis. By integrating genomics, structured clinical data, and Artificial Intelligence (AI), the project aims to provide a unified pathway that reduces waiting times and eliminates the "diagnostic odyssey" many patients face. [...]
"Navigating NMDs: Your CoMPaSS to Care," a new series of four engaging and accessible webinars designed to shed light on these conditions and the future of their diagnosis and treatment. Feeling lost in the complex world of rare neuromuscular diseases (NMDs)? You're not alone. Navigating the journey from diagnosis to care can be [...]
A groundbreaking study from the University of Modena and Reggio Emilia (UNIMORE) is changing our understanding of facioscapulohumeral muscular dystrophy (FSHD), a prevalent hereditary muscle disorder. Published in the esteemed journal Nucleic Acids Research, the research identifies a novel molecular mechanism involving a long non-coding RNA (lncRNA) called FRG2A-t, shedding new light on how [...]
The human-AI partnership is empowering clinicians in neuromuscular disorders. The ongoing conversation about artificial intelligence often pits human against machine. However, a groundbreaking editorial published today in ACTA Myologica argues that the true frontier lies not in this perceived conflict, but in the growing divide between humans who are skilled in leveraging AI and [...]
In Modena, an event brought together individuals affected by neuromuscular conditions to explore the potential of artificial intelligence in achieving more precise diagnoses and offering hope for future advancements. On Saturday, 10th May, Modena hosted an event entitled “Precision Diagnosis and Artificial Intelligence for Neuromuscular Patients: New Tools and New Possibilities”, dedicated to patients, [...]
Zebrafish: a game-changer in muscle disease research. Researchers are increasingly turning to zebrafish as a powerful model to study muscle diseases, unlocking invaluable insights into the underlying biology of conditions like muscular dystrophy. With their transparent embryos, rapid development, and genetic similarities to humans, zebrafish offer a dynamic platform for exploring disease progression and [...]